Finance
Ion-technology company announces 56% revenue growth for third quarter
Published in Medical Devices and Surgical Technology Week, June 20th, 2004
For the 3 months ended March 31, 2004, the company recorded total revenues of $2,635,000 as compared to $1,693,000 for the comparable prior-year period, an increase of $942,000 or 56%.
The increase is attributable to revenue growth in the three core business units: prostate seeds, contract manufacturing, and government contracts. Revenue of the I-Plant prostate seed for the 3 months ended March 31, 2004, was approximately $853,000 as compared to $623,000 for the comparable prior-year period, an increase of $230,000 or 37%.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Biotechnology
Encoded microcarriers enable simultaneous analysis of multiple cell types - Diagnostics
Novel method for measuring multiple cytokines from small samples - Diagnostics
Single-cell PCR useful for leptomeningeal B-cell cancer diagnosis - Drug Delivery
Thermal aerosol system enables rapid drug action - Food-Borne Illness
Rapid fluorimetric microplate assay detects seafood toxins - Proteomics
High-throughput assay measures tumor cell S-phase progression - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
